Cargando…
40 Years of CSF Toxicity Studies in ALS: What Have We Learnt About ALS Pathophysiology?
Based on early evidence of in vitro neurotoxicity following exposure to serum derived from patients with amyotrophic lateral sclerosis (ALS), several studies have attempted to explore whether cerebrospinal fluid (CSF) obtained from people with ALS could possess similar properties. Although initial f...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8012723/ https://www.ncbi.nlm.nih.gov/pubmed/33815058 http://dx.doi.org/10.3389/fnmol.2021.647895 |
_version_ | 1783673425900863488 |
---|---|
author | Ng Kee Kwong, Koy Chong Harbham, Pratap K. Selvaraj, Bhuvaneish T. Gregory, Jenna M. Pal, Suvankar Hardingham, Giles E. Chandran, Siddharthan Mehta, Arpan R. |
author_facet | Ng Kee Kwong, Koy Chong Harbham, Pratap K. Selvaraj, Bhuvaneish T. Gregory, Jenna M. Pal, Suvankar Hardingham, Giles E. Chandran, Siddharthan Mehta, Arpan R. |
author_sort | Ng Kee Kwong, Koy Chong |
collection | PubMed |
description | Based on early evidence of in vitro neurotoxicity following exposure to serum derived from patients with amyotrophic lateral sclerosis (ALS), several studies have attempted to explore whether cerebrospinal fluid (CSF) obtained from people with ALS could possess similar properties. Although initial findings proved inconclusive, it is now increasingly recognized that ALS-CSF may exert toxicity both in vitro and in vivo. Nevertheless, the mechanism underlying CSF-induced neurodegeneration remains unclear. This review aims to summarize the 40-year long history of CSF toxicity studies in ALS, while discussing the various mechanisms that have been proposed, including glutamate excitotoxicity, proteotoxicity and oxidative stress. Furthermore, we consider the potential implications of a toxic CSF circulatory system in the pathophysiology of ALS, and also assess its significance in the context of current ALS research. |
format | Online Article Text |
id | pubmed-8012723 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-80127232021-04-02 40 Years of CSF Toxicity Studies in ALS: What Have We Learnt About ALS Pathophysiology? Ng Kee Kwong, Koy Chong Harbham, Pratap K. Selvaraj, Bhuvaneish T. Gregory, Jenna M. Pal, Suvankar Hardingham, Giles E. Chandran, Siddharthan Mehta, Arpan R. Front Mol Neurosci Neuroscience Based on early evidence of in vitro neurotoxicity following exposure to serum derived from patients with amyotrophic lateral sclerosis (ALS), several studies have attempted to explore whether cerebrospinal fluid (CSF) obtained from people with ALS could possess similar properties. Although initial findings proved inconclusive, it is now increasingly recognized that ALS-CSF may exert toxicity both in vitro and in vivo. Nevertheless, the mechanism underlying CSF-induced neurodegeneration remains unclear. This review aims to summarize the 40-year long history of CSF toxicity studies in ALS, while discussing the various mechanisms that have been proposed, including glutamate excitotoxicity, proteotoxicity and oxidative stress. Furthermore, we consider the potential implications of a toxic CSF circulatory system in the pathophysiology of ALS, and also assess its significance in the context of current ALS research. Frontiers Media S.A. 2021-03-18 /pmc/articles/PMC8012723/ /pubmed/33815058 http://dx.doi.org/10.3389/fnmol.2021.647895 Text en Copyright © 2021 Ng Kee Kwong, Harbham, Selvaraj, Gregory, Pal, Hardingham, Chandran and Mehta. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neuroscience Ng Kee Kwong, Koy Chong Harbham, Pratap K. Selvaraj, Bhuvaneish T. Gregory, Jenna M. Pal, Suvankar Hardingham, Giles E. Chandran, Siddharthan Mehta, Arpan R. 40 Years of CSF Toxicity Studies in ALS: What Have We Learnt About ALS Pathophysiology? |
title | 40 Years of CSF Toxicity Studies in ALS: What Have We Learnt About ALS Pathophysiology? |
title_full | 40 Years of CSF Toxicity Studies in ALS: What Have We Learnt About ALS Pathophysiology? |
title_fullStr | 40 Years of CSF Toxicity Studies in ALS: What Have We Learnt About ALS Pathophysiology? |
title_full_unstemmed | 40 Years of CSF Toxicity Studies in ALS: What Have We Learnt About ALS Pathophysiology? |
title_short | 40 Years of CSF Toxicity Studies in ALS: What Have We Learnt About ALS Pathophysiology? |
title_sort | 40 years of csf toxicity studies in als: what have we learnt about als pathophysiology? |
topic | Neuroscience |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8012723/ https://www.ncbi.nlm.nih.gov/pubmed/33815058 http://dx.doi.org/10.3389/fnmol.2021.647895 |
work_keys_str_mv | AT ngkeekwongkoychong 40yearsofcsftoxicitystudiesinalswhathavewelearntaboutalspathophysiology AT harbhampratapk 40yearsofcsftoxicitystudiesinalswhathavewelearntaboutalspathophysiology AT selvarajbhuvaneisht 40yearsofcsftoxicitystudiesinalswhathavewelearntaboutalspathophysiology AT gregoryjennam 40yearsofcsftoxicitystudiesinalswhathavewelearntaboutalspathophysiology AT palsuvankar 40yearsofcsftoxicitystudiesinalswhathavewelearntaboutalspathophysiology AT hardinghamgilese 40yearsofcsftoxicitystudiesinalswhathavewelearntaboutalspathophysiology AT chandransiddharthan 40yearsofcsftoxicitystudiesinalswhathavewelearntaboutalspathophysiology AT mehtaarpanr 40yearsofcsftoxicitystudiesinalswhathavewelearntaboutalspathophysiology |